Fig. 4From: Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension studyPatient global impression of change and parent global impression of change in the double-blind trial. Responders were those who were very much improved or much improved at endpoint. P values for pregabalin compared with placebo for each assessment. GIC Global impression of changeBack to article page